Andrew Hopkins
Chief Executive Officer bei Kinetic Discovery Ltd.
Vermögen: 109 Mio $ am 31.03.2024
Profil
Andrew Lee Hopkins is the founder of Exscientia AI Ltd.
since 2012, where he holds the title of Chief Executive Officer & Executive Director.
He was also the founder of Exscientia Plc since 2012, where he held the title of Chief Executive Officer & Executive Director until 2024.
Dr. Hopkins's former jobs include being the Chairman-Medicinal Informatics at the University of Dundee from 2007 to 2020 and being the Director at Scottish Universities Life Sciences Alliance from 2011 to 2016.
Dr. Hopkins's education history includes a doctorate from the University of Oxford, an undergraduate degree from The University of Manchester, and a doctorate from the University of Dundee.
Dr. Hopkins is also the founder of Kinetic Discovery Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EXSCIENTIA PLC
16,17% | 01.03.2024 | 19 124 900 ( 16,17% ) | 109 Mio $ | 31.03.2024 |
Aktive Positionen von Andrew Hopkins
| Unternehmen | Position | Beginn |
|---|---|---|
Kinetic Discovery Ltd.
 Kinetic Discovery Ltd. Pharmaceuticals: MajorHealth Technology Kinetic Discovery Ltd. engages in the provision of drug discovery services. It offers full kinetic characterization, compound screening, fragment based screening, membrane protein analysis, active concentration determination, epitope mapping, promiscuous binding identification, and consultancy and assay development. The company was founded by Iva Navratilova and Andrew L. Hopkins and is headquartered in Dundee, the United Kingdom. | Chief Executive Officer | - |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Founder | 01.07.2012 |
Ehemalige bekannte Positionen von Andrew Hopkins
| Unternehmen | Position | Ende |
|---|---|---|
| EXSCIENTIA PLC | Founder | 13.02.2024 |
| University Of Dundee | Corporate Officer/Principal | 01.01.2020 |
| Scottish Universities Life Sciences Alliance | Director/Board Member | 01.01.2016 |
Ausbildung von Andrew Hopkins
| University of Oxford | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University Of Dundee | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Kinetic Discovery Ltd.
Kinetic Discovery Ltd. Pharmaceuticals: MajorHealth Technology Kinetic Discovery Ltd. engages in the provision of drug discovery services. It offers full kinetic characterization, compound screening, fragment based screening, membrane protein analysis, active concentration determination, epitope mapping, promiscuous binding identification, and consultancy and assay development. The company was founded by Iva Navratilova and Andrew L. Hopkins and is headquartered in Dundee, the United Kingdom. | Health Technology |
| Exscientia Plc | |
| Scottish Universities Life Sciences Alliance |
